Perbedaan DCI Indonesia Tbk dan UBC Medical Indonesia Tbk.: DCI Indonesia Tbk diperdagangkan di Rp198.675 (kapitalisasi pasar 473,71 T, volume 24 jam 1 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: DCI Indonesia Tbk jauh lebih besar — sekitar 810,3× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DCII | LABS | |
|---|---|---|
Kapitalisasi Pasar | 473,71 T | 584,6 M |
Volume | 1 rb | 817,3 rb |
Lot | 10 | 8,17 rb |
Perputaran | 194,12 jt | 120,01 jt |
Harga Rata-rata | 194.120 | 146,84 |
Nilai Transaksi | 194,12 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 199.000 | 146 |
Volume Ekuilibrium Indikatif | 1 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT DCI Indonesia Tbk (the Company) was established in Indonesia based on Notarial Deed No. 143 of Buntario Tigris, S.H., S.E., M.H., on July 18, 2011. The Company started its commercial operations in 2013. The Company parent entity and ultimate controlling party is DCI International Holding Pte. Ltd., Singapore.
Selengkapnya di halaman DCII →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →